---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-037020"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2022-03-23T23:59:59+00:00"
generated_at: "2026-06-26T19:39:53.927902+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech raises $10M in registered direct offering at $3.65/share

## Summary
- Gross proceeds of $10.0M from sale of 2,739,727 common shares or equivalents at $3.65/share.
- Concurrent private placement of warrants to purchase 2,739,727 shares at $3.52, exercisable immediately for 5.5 years.
- Offering expected to close March 24, 2022; net proceeds for working capital and general corporate purposes.
- Terminated equity distribution agreement with RBC Capital Markets; $2.94M raised under that agreement through termination.
- H.C. Wainwright acted as exclusive placement agent with 7% cash fee and 191,780 placement agent warrants.

## SEC filing metadata
- accession: 0001104659-22-037020
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2022-03-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000110465922037020/0001104659-22-037020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000110465922037020/tm2210153d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-037020
- JSON: https://secwatch.observer/filing/0001104659-22-037020.json
- Plain text: https://secwatch.observer/filing/0001104659-22-037020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.